div class=trans-pagebuttonPage 1button div class=trans-image a href=https:reader039fdokumencomreader039viewer20230430116336d6ef6d3688ab500022c1html5page1jpg target=_blank amp-img class=trans-thumb alt=Page 1: beta2-microglobulin in Hodgkins lymphoma: prognostic significance in patients treated with ABVD or equivalent regimens src=https:reader039fdokumencomreader039viewer20230430116336d6ef6d3688ab500022c1html5thumbnails1jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 2button div class=trans-image a href=https:reader039fdokumencomreader039viewer20230430116336d6ef6d3688ab500022c1html5page2jpg target=_blank amp-img class=trans-thumb alt=Page 2: beta2-microglobulin in Hodgkins lymphoma: prognostic significance in patients treated with ABVD or equivalent regimens src=https:reader039fdokumencomreader039viewer20230430116336d6ef6d3688ab500022c1html5thumbnails2jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 3button div class=trans-image a href=https:reader039fdokumencomreader039viewer20230430116336d6ef6d3688ab500022c1html5page3jpg target=_blank amp-img class=trans-thumb alt=Page 3: beta2-microglobulin in Hodgkins lymphoma: prognostic significance in patients treated with ABVD or equivalent regimens src=https:reader039fdokumencomreader039viewer20230430116336d6ef6d3688ab500022c1html5thumbnails3jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 4button div class=trans-image a href=https:reader039fdokumencomreader039viewer20230430116336d6ef6d3688ab500022c1html5page4jpg target=_blank amp-img class=trans-thumb alt=Page 4: beta2-microglobulin in Hodgkins lymphoma: prognostic significance in patients treated with ABVD or equivalent regimens src=https:reader039fdokumencomreader039viewer20230430116336d6ef6d3688ab500022c1html5thumbnails4jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 5button div class=trans-image a...